Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Joki (Tokyo, Japan), H. Konishi (Tokyo, Japan), K. Takasu (Tokyo, Japan), K. Shimada (Tokyo, Japan). Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease.. 1492

Member's Comments

No comment yet.

Related content which might interest you: Under pressure: pulmonary hypertension associated with left heart disease Source: Eur Respir Rev 2015; 24: 665-673 Year: 2015 Fibrinogen plasma levels and disease severity in pulmonary artery hypertension Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 How to define pulmonary hypertension due to left heart disease Source: Eur Respir J 2016; 48: 553-555 Year: 2016 Pulmonary hypertension associated with left heart disease Source: Eur Respir Mon 2012; 57: 119-137 Year: 2012 Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012 Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? Source: Eur Respir J 2013; 42: 888-890 Year: 2013 Serum osteoprotegerin expression correlates with disease progression and severity in rodent models of pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Pulmonary hypertension due to left heart disease Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018 Year: 2019 Relation between hemodynamics and right ventricular hypertrophy may affect survival and severity of the disease in patients with primary pulmonary hypertension (PPH) Source: Eur Respir J 2002; 20: Suppl. 38, 26s Year: 2002 Pulmonary hypertension in left heart disease Source: Eur Respir Rev 2012 21: 338-346 Year: 2012 Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension and their relationship with right ventricular structure and function Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018 Year: 2019 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018 Year: 2019 Initial experience of sildenafil in patients with congenital heart disease (CHD) associated pulmonary arterial hypertension (PAH) Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006 Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017 Year: 2018 How to detect disease progression in pulmonary arterial hypertension Source: Eur Respir Rev 2012; 21: 40-47 Year: 2012 Usefulness of differential blood gas exchange assessment in patients with severe pulmonary arterial hypertension (PAH) associated to congenital heart disease (CHD) Source: Eur Respir J 2005; 26: Suppl. 49, 351s Year: 2005